Edition:
United States

ChemoCentryx Inc (CCXI.OQ)

CCXI.OQ on NASDAQ Stock Exchange Global Select Market

5.87USD
15 Dec 2017
Change (% chg)

$0.20 (+3.53%)
Prev Close
$5.67
Open
$5.66
Day's High
$5.94
Day's Low
$5.65
Volume
166,511
Avg. Vol
39,140
52-wk High
$10.80
52-wk Low
$5.65

Chart for

About

ChemoCentryx, Inc. is a biopharmaceutical company. The Company is engaged in developing new medications targeted at inflammatory disorders, autoimmune diseases and cancer. Each of its drug candidates focuses on a specific chemoattractant receptor that selectively blocks its negative inflammatory or suppressive response, leaving... (more)

Overall

Beta: 1.52
Market Cap(Mil.): $276.17
Shares Outstanding(Mil.): 48.71
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 32.50 16.04
EPS (TTM): -- -- --
ROI: -- 15.11 35.70
ROE: -- 16.59 15.40

BRIEF-Chemocentryx reports Q3 revenue $9.0 million

* Chemocentryx reports third quarter 2017 financial results and recent highlights

Nov 07 2017

BRIEF-ChemoCentryx qtrly basic and diluted net loss per share $0.19

* ChemoCentryx reports second quarter 2017 financial results and recent highlights

Aug 08 2017

Competitors

Earnings vs. Estimates